Correlation Between InfoBank and Daihan Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both InfoBank and Daihan Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InfoBank and Daihan Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InfoBank and Daihan Pharmaceutical CoLtd, you can compare the effects of market volatilities on InfoBank and Daihan Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InfoBank with a short position of Daihan Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of InfoBank and Daihan Pharmaceutical.

Diversification Opportunities for InfoBank and Daihan Pharmaceutical

0.82

Correlation Coefficient

InfoBank  Daihan Pharmaceutical

Very poor diversification

The 3 months correlation between InfoBank and Daihan is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding InfoBank and Daihan Pharmaceutical CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daihan Pharmaceutical and InfoBank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InfoBank are associated (or correlated) with Daihan Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daihan Pharmaceutical has no effect on the direction of InfoBank i.e., InfoBank and Daihan Pharmaceutical go up and down completely randomly.

Pair Corralation between InfoBank and Daihan Pharmaceutical

Assuming the 90 days trading horizon InfoBank is expected to generate 4.94 times more return on investment than Daihan Pharmaceutical. However, InfoBank is 4.94 times more volatile than Daihan Pharmaceutical CoLtd. It trades about 0.31 of its potential returns per unit of risk. Daihan Pharmaceutical CoLtd is currently generating about 0.24 per unit of risk. If you would invest  560,194  in InfoBank on October 10, 2024 and sell it today you would earn a total of  211,806  from holding InfoBank or generate 37.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

InfoBank  vs.  Daihan Pharmaceutical CoLtd

InfoBank

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in InfoBank are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, InfoBank sustained solid returns over the last few months and may actually be approaching a breakup point.

Daihan Pharmaceutical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Daihan Pharmaceutical CoLtd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with InfoBank and Daihan Pharmaceutical

The main advantage of trading using opposite InfoBank and Daihan Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InfoBank position performs unexpectedly, Daihan Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will offset losses from the drop in Daihan Pharmaceutical's long position.

The idea behind InfoBank and Daihan Pharmaceutical CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.